13D/13G Filings - Altamont Pharmaceutical Holdings LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-04-03
08:08 am
Unchanged
2024-04-01 13G Galera Therapeutics, Inc.
GRTX
Altamont Pharmaceutical Holdings LLC 0
0.000%
0
(Unchanged)
Filing
History
2023-11-13
2:24 pm
Purchase
2023-10-31 13G Galera Therapeutics, Inc.
GRTX
Altamont Pharmaceutical Holdings LLC 5,280,000
12.020%
5,280,000increase
(New Position)
Filing
History
2020-05-06
4:01 pm
Sale
2020-04-30 13G Soligenix, Inc.
SNGX
Altamont Pharmaceutical Holdings LLC 2,966
2.800%
-2,500decrease
(-45.74%)
Filing
History